Sol-Gel Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLGL and other ETFs, options, and stocks.About SLGL
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T.
CEOMoshe Arkin
CEOMoshe Arkin
Employees34
Employees34
HeadquartersNess Ziona, Tel Aviv
HeadquartersNess Ziona, Tel Aviv
Founded1997
Founded1997
Employees34
Employees34
SLGL Key Statistics
Market cap20.61M
Market cap20.61M
Price-Earnings ratio-1.58
Price-Earnings ratio-1.58
Dividend yield—
Dividend yield—
Average volume7.05K
Average volume7.05K
High today$7.48
High today$7.48
Low today$7.40
Low today$7.40
Open price$7.40
Open price$7.40
Volume1.15K
Volume1.15K
52 Week high$16.50
52 Week high$16.50
52 Week low$3.34
52 Week low$3.34
People also own
Based on the portfolios of people who own SLGL. This list is generated using Robinhood data, and it’s not a recommendation.